Professional
Added to YB: 2024-09-24
Pitch date: 2024-06-30
BSX [bullish]
Boston Scientific Corporation
+19.77%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$144.6B
Pitch Price
$77.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
30.09
P/E
52.15
EV/Sales
8.04
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Janus Henderson Enterprise Fund Portfolio Holding: Boston Scientific Corporation
BSX: Stock up on FARAPULSE US launch, state-of-the-art pulsed field ablation system for atrial fibrillation with less tissue damage. Only provider in large, growing market. Diversified product portfolio offers multiple revenue growth drivers.
Read full article (1 min)